OncoScreen Plus / 6-Gene Panel
Therapy selection for solid tumors (via tissue)
ApprovedCommercial
Key Facts
Indication
Therapy selection for solid tumors (via tissue)
Phase
Approved
Status
Commercial
Company
About Burning Rock Biotech
Burning Rock Biotech is a publicly-traded, commercial-stage diagnostics company specializing in precision oncology. Its core mission is to transform cancer treatment through early detection and personalized therapy selection using advanced genomic profiling. The company has established a significant commercial footprint in China with its portfolio of NGS-based in-vitro diagnostic (IVD) products and laboratory-developed tests (LDTs), while actively developing its multi-cancer early detection (MCED) pipeline. Its strategic direction involves expanding its product portfolio, pursuing regulatory approvals, and exploring international markets.
View full company profile